Shares of Ocular Therapeutix Inc. (NASDAQ:OCUL) traded today at $20.70, eclipsing its 52-week high. So far today approximately 603,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye.
There is potential upside of 5.5% for shares of Ocular Therapeutix Inc. based on a current price of $20.57 and an average consensus analyst price target of $21.71.
In the past 52 weeks, shares of Ocular Therapeutix Inc. have traded between a low of $3.69 and a high of $20.70 and is now at $20.57, which is 457% above that low price.
Receive IBN`s Technical Indicator Alerts
To stay connected with our complimentary IBN alerts, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer